UAB researchers seek Friedreich’s ataxia biomarkers

UAB News, University of Alabama at Birmingham, November 04, 2015

“There is a high demand for biomarkers because of ongoing clinical trials with Friedreich’s ataxia patients,” said Marek Napierala, Ph.D., assistant professor in UAB Department of Biochemistry and Molecular Genetics, UAB Stem Cell Institute. “We need better measures of the progression of the disease and the therapeutic response.”


 UAB researchers seek Friedreich’s ataxia biomarkers